State Development & Investment Corporation

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion. SDICVC puts into practice the marketization and industrialization of the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.
DC

Dechun Chen

VP

ZG

Zhong Guodong

VP

MQ

Meng Qian

VP

LR

Li Ruge

CFO

DW

Du Wenmin

VP

YX

Yang Xiaohui

VP

HZ

Hua Zhang

CFO

90 past transactions

Hangzhou Nationalchip Science&Technology Co, Ltd. focuses on IC design and system solution development in the fields of digital television, home multimedia, and artificial intelligence (AI). The company offers demodulator, and decoder and video post processing IC series, as well as demodulator, decoder, and video post processing SoC IC solutions for satellite, cable, terrestrial, and mobile transmitted DTV areas. It also provides embedded SoC chip designed for AI, IoT, AI voice, and intelligent voice front-end signal processing applications, as well as YOC solutions. The company was founded in 2001 and is based in Hangzhou, China.

HiGo

Angel Round in 2017
HiGo is an intelligent driving control system developer company.

Yinglai Technology

Series B in 2019
Intelligent Laser is a developer of robotic laser vision systems, mainly engaged in the development and production of laser vision systems. At the same time, it cooperates with Tangshan Yinglai Machine Vision Engineering Technology Application Center to provide users with solutions for laser vision sensors for industrial robots.

Aucta Pharmaceuticals

Series A in 2021
Provider of a drug development platform intended to improve drug delivery and develop novel and niche generic medical products. The company's drug development platform is poorly water soluble, features controlled release and specializes in central nervous system and oncology compound, enabling pharmaceuticals companies to develop drugs and drug-based products based on patient compliance.

HQ Education

Series A in 2019
HQ Education is an O2O education service platform.
PhotonIC Technologies is an optoelectronic integrated circuit chips provider. PhotonIC Technologies focus on designing, developing, and commercializing high-speed/low-power optoelectronic integrated chips for data center, 5G transmission, 3D ToF smart sensing and other fields.

BYD

Venture Round in 2020
BYD is engaged in the research, development, manufacture, and distribution of automobiles, secondary rechargeable batteries, and mobile phone components. The company operates its businesses primarily through its secondary rechargeable battery business that provides lithium-ion batteries and nickel batteries which are applied in mobile phones, digital cameras, electric tools, electric toys, and other portable electronic devices; mobile phone components and assembly businesses which offer casings, keypads, liquid crystal display (LCD) modules, cameras, flexible circuit boards, chargers, and mobile phone design and assembly services; and automobile business which provides automobiles, including G6, S6, and other series.
Inceptio Technology provides a nation-wide freight network using autonomous driving trucks. It focuses on the transformation of line-haul logistics by providing a more secure, efficient, and economical transportation-As-A-Service to logistic customers. The company's autonomous driving heavy-duty trucks utilize artificial intelligence technology, new energy technology, and logistics big data technology, providing logistics companies with efficient and safe logistic solutions. It was founded in 2018 and is based in Jiangxi, China.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.
Twenty First Century Aerospace Technology Co., Ltd operates commercial earth observation (EO) satellites, and provides data and information services. The company operates EO small satellites, including the 1m optical EO small satellite constellation, and satellite control and image tasking and receiving stations. It provides products and services for the entire space geo-information value chain that range from satellite procurement/financing, satellite housekeeping, payload and satellite resources management, tasking, data acquisition, image processing, hosting/archiving, data management/distribution, multiple satellite source integration through its Web portal, and geo-information services to application software development and integrated solutions. The company offers imaging data, including programmed and archiving data; value added images, geo-information services, and spatial remote sensing services; image data processing software, database, Web portal development, smart satellite resource management and operation, and automatic and intelligent tasking software development, as well as direct image receiving. Its geo-information services cover a range of information products and services; including land cover theme imagery, change investigation, data statistics and analysis, 3D simulation, and professional consultancy for spatial information applications to serve government administration, public services, and commercial markets. The company also provides information extraction, operational monitoring, system platform, and ground station services. Its solutions are used for intelligence city management, living resources, energy and natural resources, eco-environment, disaster and emergency response, and industrial applications. The company was founded in 2001 and is based in Beijing, China.
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

G7

Private Equity Round in 2022
G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

Yihui Information

Series B in 2022
Yihui Information is a high-tech enterprise with complete independent intellectual property rights

Cambricon Technologies

Series B in 2018
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

MabPlex International Ltd

Series A in 2019
MabPlex International Ltd provides contract development and manufacturing of biopharmaceuticals including, monoclonal antibodies (mAbs), recombinant proteins, Antibody Drug Conjugates (ADCs) and bispecifics. It offers customized mammalian cell medium, cell banking, monoclonal antibodiy active pharmaceutical ingredient (API) manufacturing, and biologics and ADC fill and finish manufacturing. The company was founded in 2013 and is based in Yantai, China with an additional office in Fremont, California.
HUITONGDA Network Co., Ltd. provides online merchandising and marketing to retail outlets. It helps offline stores sell goods via e-commerce and also provides infrastructure for e-commerce retailers to sell to rural residents. The company sells air-conditioning, color TV, refrigerator, and washing machine to rural customers. HUITONGDA Network Co., Ltd. was founded in 2008 and is based in Nanjing, China. The company operates as a subsidiary of Jiangsu Five Star Appliance Co., Ltd.
Nanjing Tianfu Software Co., Ltd. develops custom software solutions for various industries, such as turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. The company founded in 2011 and is based in Nanjing, China.

BrightGene

Venture Round in 2019
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

Zhiyi Pharmaceutics Inc.

Series B in 2020
Zhiyi Pharmaceutics Inc., a biopharmaceutical company, is engaged in research and development of NGPs (next-generation probiotics) and LBPs (live biotherapeutics). The company’s products include SK08, TP2, ZY19, and SK09. Its products can be used for treating gastrointestinal disorders. Zhiyi Pharmaceutics Inc. was founded in 2013 and is headquartered in Guangzhou, China.

MoonBiotech

Series C in 2021
Guangzhou Based Healthcare Start up.

Remegen

Private Equity Round in 2019
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.

Eucure Biopharma

Series A in 2016
Eucure (Beijing) Biopharma Co., Ltd discovers and develops immuno-oncology targeted antibodies. It offers antibody production, in vivo drug efficacy, and in vitro efficacy test. Its pipeline drugs include YH-001, YH-002, YH-003, YH-004, YH-005, YH-006, YH-007, and YH-008. The company was founded in 2016 and is headquartered in Beijing, China. As of August 31, 2020, Eucure (Beijing) Biopharma Co., Ltd operates as a subsidiary of Beijing Biocytogen Co., Ltd.

OMNI

Series B in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.

Aluksen Technology

Series B in 2022
Aluksen Technology is an industry leading semiconductor chip manufacturer specializing in optoelectronic technology. The R&D center is located in Silicon Valley, USA. We focus on the telecom, industrial and consumer electronics markets, and gradually form a marketing and service network with Shenzhen as the operation center and covering the global region. We will continue to innovate around customer needs and strive to provide high customers. Quality products and fast, professional technical support and services.

ECTEK

Post in 2017
Changzhou ECTEK Automotive Systems CO., Ltd researches, develops, manufactures, and sells electrical automotive products. The company offers vehicle control systems, test bench and control systems, electronic control unit (ECU) test systems, and diesel electric control systems. Changzhou ECTEK Automotive Systems CO., Ltd supplies its products to marine, locomotive, construction machinery, and other power industries. The company was founded in 2005 and is based in Changzhou, China.

Bangsun Technology

Series C in 2019
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Realmax

Series A in 2017
Realmax Technology Limited is a high tech company in augmented reality (AR).

Robotleo

Series B in 2018
Robotleo manufactures robots for domestic use. The company was founded in 2014 and is based in Beijing, China.

Ractigen Therapeutics

Series A in 2022
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.

Abogen Biosciences

Series A in 2020
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Abogen Biosciences

Series B in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

OMNI

Series C in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

SVOLT

Series B in 2021
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.

Porton Biologics

Series A in 2021
Porton Biologics provides end-to-end gene/therapy CDMO service for innovators from the early stage, IND filling, and commercial production.

Eucure Biopharma

Series A in 2017
Eucure (Beijing) Biopharma Co., Ltd discovers and develops immuno-oncology targeted antibodies. It offers antibody production, in vivo drug efficacy, and in vitro efficacy test. Its pipeline drugs include YH-001, YH-002, YH-003, YH-004, YH-005, YH-006, YH-007, and YH-008. The company was founded in 2016 and is headquartered in Beijing, China. As of August 31, 2020, Eucure (Beijing) Biopharma Co., Ltd operates as a subsidiary of Beijing Biocytogen Co., Ltd.

Huangdi

Series B in 2015
Guizhou Huangdi Technology Co., Ltd. manufactures emission controlling solutions for tunnel and cave machines, ships, forklifts, buses, trucks, generation units, explosion-proof mining machines, non-explosion-proof mining machines, and special vehicles. Its products include diesel particulate filters, ART type active regeneration particular filter systems, fuel borne catalysts, and diesel particulate filter cleaners. The company partners with engine makers and OEMs in the United Kingdom, France, Italy, Portugal, Singapore, the United States, Venezuela, the United Arab Emirates, Indonesia, Hong Kong, Macau, and internationally. Guizhou Huangdi Technology Co., Ltd. was founded in 2008 and is based in Guiyang City, China.

Jaka Robot

Series C in 2021
Jaka Robot develops, engineers, manufactures, and markets industrial robots. Its products include JAKA ZuTM robot, which is a wireless control system that collaborates with mobile applications; JAKA MES, which helps in information integration across various departments in a factory; conveyor systems; palletizing robot systems; and liner molding machines. The company caters to food and beverage, chemical, packaging, electronics, and mechanical processing industries. The company was founded in 2014 and is based in Shanghai, China.
Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. It offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. The company was founded in 1972 and is based in Xianju, China.
Ascentage Pharma Group Corporation, Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of small-molecule targeted therapeutics for addressing cancers, hepatitis B, and age-related diseases. It has strategic alliance with Genor Biopharma Co. Ltd. The company was founded in 2009 and is based in Shanghai, China with locations in Suzhou and Taizhou, China; and Rockville, Maryland.

BGI Tech

Post in 2021
Shenzhen Huada Gene Technology Co. Ltd. operates as a biotech development company. The Company provides bioinformatics testing, genetic testing, agricultural genomics researching, proteomics researching, and other services. Shenzhen Huada Gene Technology conducts business in China.

Video++

Series B in 2018
Video++ provides video-streaming services for users within and outside China. It began operation in April 2014, with its headquarters in Shanghai in China.

Everbright Photonics

Series B in 2018
Everbright Photonics is a Smart Hardware company.
Jiangsu Changhong Intelligent Equipment Group Co., Ltd. designs and manufactures automotive production lines. The company offers design, manufactures, and installation services for welding line such as auto-body lateral assembly line, auto-body door cover assembly line, bottom plate assembly line, and auto body main welding line. It also offers design and manufacturing services for coating lines such as electrophoresis, drying and forced cooling, fine sealing, top coating preparation, and skid conveyor lines; and for assembly production lines such as interior trims, chassis, engine subassembly, and rear side subassembly. The company was founded in 1989 and is based in Yancheng, China.

Casiris Vision

Series D in 2019
Casiris Vision is a limited liability company jointly invested by the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Hangzhou Economic and Technological Development Zone, venture capital and technical team. The company is committed to R&D and production challenges. A pure laser display product with a human visual limit. In 2016, it was recognized as a national high-tech enterprise, a high-tech enterprise in Hangzhou, a technology-based enterprise in Zhejiang and Hangzhou Economic and Technological Development Zone. At present, Zhongke Aurora has 5,500 square meters of automated light source and complete machine production line, providing laser light source applications to home theater, engineering projection, film and lighting engineering complete solutions.

WM Motor

Series D in 2020
WM Motor is an automotive company that designs, manufactures, develops, and markets energy and battery-operated vehicles. It provides energy vehicle products and travel solutions to its customers. The company aims to conserve electronic vehicles in addition to intelligent data hardware, enabling consumers to utilize smart cars that are efficient and energy conserving. WM Motor’s products are built with three core technologies, the Living Motion electric powertrain, the Living Pilot intelligent driving assistance system, and the Living Engine operating system, which offers industry-leading smart connectivity and interactive features.
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

ZETTASTONE

Angel Round in 2018
Beijing Zettastone Technology Co., Ltd. is a solid state hard disk company based in Beijing, China.
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Bangsun Technology

Series B in 2018
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Biostar Technologies

Series B in 2019
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

Cambricon Technologies

Series A in 2017
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

Joy Next

Venture Round in 2020
Joy Next is a smart cockpit and automobile systems platform.

Feilongyu

Angel Round in 2017
Guizhou Feilongyu Industrial Group Co., Ltd. engages in the production and sales of water for consumption. The company was founded in 1993 and is based in Guiyang, China.

Skyguard

Series A in 2017
Beijing SkyGuard Network Security Technologies LLC provides network information security technology services. The company was founded in 2015 and is based in Beijing, China.

KBP Biosciences

Series A in 2018
KBP BioSciences Co., Ltd., a biotechnology company, engages in the research and development of drugs focusing on infectious and metabolic diseases in China. The company’s research platform includes structure based drug design, in vitro and cell based biological screening, screening of pharmacodynamic and pharmacokinetic evaluation, ADME profiling, and pre-clinical animal pharmacology and toxicity analysis. Its services include transfer of new dugs, licensing, and intellectual property (IP) protection, as well as IP services in patent scope and novelty analysis, and patent writing and filing services. KBP BioSciences Co., Ltd. was founded in 2002 and is headquartered in Jinan, China with additional offices in Beijing, China; Japan; and the United States.

Enmotech

Series B in 2017
Enmotech (Beijing) Information Technology Co., Ltd. provides solutions and professional services for data/database systems and related areas. The company’s products and services include security, performance optimization, integration, and others. It also offers technical services, such as distributed architecture, high availability disaster recovery, SQL audit, operation and maintenance, performance monitoring, professional training, and data model optimization. In addition, the company provides software that comprise Bethune, an IT system health automated inspection platform; zCloud database cloud service management platform; SQM – SQL quality control platform; zData database machine; and MyData, an automated operation and maintenance management platform. It serves customers in financial services, communication operation, energy transportation, government/public utility, and manufacturing/trade markets. The company was founded in 2009 and is based in Beijing, China.
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Everbright Photonics

Series C in 2020
Everbright Photonics is a Smart Hardware company.

DigiHuman

Post in 2018
Shandong Digihuman Technology Co.,Inc designs and develops digital human body system and application software solutions. The company offers China Digihuman Anatomy System, digital medical image processing, human body big data, and digital medical teaching platform. It offers various solutions, including medical education, life science education, clinical treatment, Digihuman cloud platform. The company serves the medicine, clinics, science popularization, aviation, and military fields. Shandong Digihuman Technology Co.,Inc was formerly known as Shandong Yichuang Electronics Co., Ltd. and changed its name to Shandong Digihuman Technology Co.,Inc in August 2015. The company was founded in 2002 and is based in Jinan City, China.

DTStack

Series B in 2019
Kangaroo Cloud (quasi-unicorn enterprise) owns two digital technology subsidiaries, cloud technology and cloud technology, mainly for retail, finance, government, tourism, internet and other industries, providing digital stacks including DTinsight, data visualization, and data center solutions. Big data and cloud technology products and services, including solutions and cloud MSPs, help companies achieve digital transformation and promote industrial innovation and social progress.

Allist Pharmaceuticals

Series A in 2019
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the discovery, development, and commercialization of pharmaceutical products for human health in China and internationally. It offers generic and branded pharmaceuticals for the treatment of cardiovascular, acid related, and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.